ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Letter to the Editor

Fatal Lymphangiosarcoma Revealed by Lymphoedema of the Neck

doi: 10.2340/00015555-0628

Abstract:

This article does not have an abstract.

Authors:

Nathalie Lalanne, Khaled Ezzedine, Béatrice Vergier, François Liferman, Alain Taieb and Thomas Jouary

References

  • Spieth K, Gille J, Kaufmann R. Therapeutic efficacity of interferon alfa-2a and 13-cis retinoic acid in recurrent angiosarcoma of the head. Arch Dermatol 1999; 135: 1035–1037.
  • Fletcher CD, Unni KK, Mertens F, editors. World Health Organization. Classification of tumors. Tumors of soft tissue and bone. Lyon: IARC Press, 2002.
  • Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer 1996; 77: 2400–2406.
  • Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber G, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999; 154: 385–394.
  • Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol 2002; 15: 434–440.
  • Verdier E, Carvalho E, Young P, Musette P, Courville P, Joly P. Lymphangiosarcoma treated with liposomal doxorubicin (Caelyx). Ann Dermatol Venereol 2007; 134: 760–763.
  • Related articles

    There are no related articles.


    Share with your friends





    Actions


    Abstract

    Full text

    PDF

    Supplementary


    There is no supplementary for this article.

    Print information


    Volume 89, Issue 3

    DOI: 10.2340/00015555-0628

    Pages: 318-319

    View at PubMed